Vaxxilon
Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines.
Vaxxilon operates in biotechnology, pharmaceutical based in Europe, Middle East, and Africa (EMEA), founded in 2015.
Its activity falls under biotechnology, pharmaceutical; the profile below is assembled from public directory data.
Its base of operations is Europe, Middle East, and Africa (EMEA).
It is recorded at the Grant stage.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $1.4M.
| Sector | Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2015 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $1,400,000 |
Website: vaxxilon.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account